Medical Technology Stock Letter

BioInvest.com is the web home of the Medical Technology Stock Letter, an industry leading newsletter covering the biotech sector for almost thirty years.  Seeking information on FDA Approvals, Biotech Mergers & Acquisitions, Stock Picks, Long Investments and the occassional Short Sale?  Trying to stay on the cutting edge of scientific developments so you can stay ahead of the Markets? 

The Medical Technology Stock Letter is the source for Biotechnology news and investing advice.  Forget the pundits and the trends.  Here you find only experienced insight and the details that Wall Street doesn't want you to know.

Request a Free Issue then go to the Newsletter page to find out what's new at MTSL.

Subscribers, click here to log in or go directly to the Subscriber area.

Search BioInvest.com
Loading
Latest News from Yahoo! Finance

May 7, 2009

DateThursday, May 7, 2009 at 11:48AM

As mentioned in the previous issue, we sold all remaining BCRX positions in the Model Portfolio and Trader’s Portfolio using the closing price of $1.85 of from Monday, April 20th.

We also bought 2000 shares of BMRN (at $12.27/share) and 5000 shares of SGMO (at $4.65/share) in the Model Portfolio and 2000 shares of BMRN and 5000 shares of SGMO in the Trader’s Portfolio. A 1% commission was charged on each transaction.

AuthorAdministrator | Comments Off |